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The search for novel ways to target and alter the
genomes of living organisms accelerated rapidly this
decade with the discovery of CRISPR/Cas9. Since the
initial discovery, efforts to find alternative methods
for altering the genome have expanded. A new
study presenting an alternative approach has been
demonstrated that utilizes flap endonuclease 1
(FEN-1) fused to the Fok1 endonuclease, which
shows potential for DNA-guided genome targeting
in vivo.an international team of researchers led by JenniferIntroduction
With the explosion of interest in “genome editing” aris-
ing following the demonstration that Cas9 acts as an
RNA-guided nuclease (i.e., RNA sequences are used to
guide nuclease activity to a specific DNA sequence),
researchers have worked tirelessly to discover novel
ways to manipulate the genome and gene expression.
This effort has resulted in a number of new genes
and approaches using other RNA-guided nucleases,
DNA-guided nucleases, synthetic transcription factors,
and other exciting techniques. The latest approach,
published in the current issue of Genome Biology [1],
uses an enzyme involved in DNA repair and replica-
tion known as flap endonuclease 1 (FEN-1) fused to
the Fok1 endonuclease. Xu and colleagues [1] have
shown that this strategy results in a DNA-guided nu-
clease that, when injected, can efficiently cause large
deletions in the zebrafish genome in vivo. This repre-
sents a significant new tool in the genome editing
toolbox.* Correspondence: burgess@mail.nih.gov
2Translational and Functional Genomics Branch, National Human Genome
Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeRNA-guided genome editing
Targeted genome engineering has come a long way
since the first publication describing the zinc-finger
fusions to Fok1 endonuclease in 1996. For many
years, programmable zinc-finger nucleases (ZFNs),
and more recently transcription activator-like effector
nucleases (TALENs), were used for generating tar-
geted genomic manipulations [2]. Each target of these
nucleases involved a re-engineering of the protein dir-
ectly, so these approaches required significant levels
of expertise and were often laborious to construct.
Thus, they were not widely adopted. In August 2012,
Doudna and Emmanuelle Charpentier published a
landmark paper describing the use of the class II
CRISPR/Cas9 system from Streptococcus pyogenes for
gene editing. They demonstrated that three of the
components (crRNA, tracrRNA, and Cas9 protein)
could be used to generate DNA double-stranded
breaks in vitro in a sequence-specific manner [3]. The
simplicity and robustness of this approach has re-
sulted in no less than a revolution in genome editing
in less than a decade [4].
For CRISPR/Cas9, any sequence in the genome can be
targeted that has a protospacer adjacent motif (PAM)
immediately downstream of the target site (NGG or
NAG for spCas9) and this targeting has worked in es-
sentially every organism tested [4]. Cas9 proteins from
different bacterial species have different PAM sequences
and many of them are being tested for their utility as
genome-editing tools [5]. Thus far, CRISPR/Cas9-based
tools are being used for a constantly growing list of ap-
plications, including genomic modifications, epigenetic
regulation, functional-genomics screens, live imaging of
genomes, and gene therapy [4, 5]. The quest for expand-
ing the CRISPR-based genome editing toolbox has un-
covered many other similar proteins by analyzing
microbial genomes and metagenomic data. In suchle is distributed under the terms of the Creative Commons Attribution 4.0
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class II CRISPR systems, such as Cpf1, C2c1, C2c2, and
C2c3 [6]. The endonuclease Cpf1 has been shown to
work in in vivo genome editing; C2c2 has endoribonu-
clease activity with the ability to edit RNA; and these
other enzymes could further revolutionize the genome
editing toolbox. By increasing the number of available
PAM sites with new class II components such as Cpf1,
or targeting RNA instead of DNA in the case of C2c2,
the “target space” of the genome increases, making more
types of editing possible.
DNA-guided genome editing
Genome editing mediated by Natronobacterium gregoryi
NgAgo
The rapid progress adapting Cas9 into a ubiquitous tool of
molecular biology research further motivated researchers
to look for additional alternatives for genome editing. In
this quest, a group from China led by Chunyu Han has
developed a DNA-guided genome editing method using
the Argonaute protein from Natronobacterium gregoryi
(NgAgo) [7]. Argonaute from Thermo thermophiles
(TtAgo) has previously been shown to edit plasmid
DNA at non-physiological temperatures (>65 °C) [8]. In
the Han group publication, the Argonaute protein
NgAgo was able to edit DNA in cell culture at 37 °C.
The NgAgo-mediated genome editing requires a 5′-
phosphorylated 24-nucleotide DNA guide and the
Argonaute protein. This new method generated tre-
mendous excitement within the scientific community,
in part because, in contrast to CRISPR/Cas9, NgAgo
did not have any sequence constraints. Han and col-
leagues showed that purified Argonaute protein, together
with a guide DNA, could cleave plasmids in vitro. While
these results were very exciting, reproducibility has been a
nagging issue and the utility or validity of this approach is
still in question [9].
Genome editing mediated by a structure-guided
endonuclease
A recent study published in the current issue of Genome
Biology by Xu and colleagues potentially adds yet an-
other tool—structure-guided endonuclease (SGN)—to
the rapidly increasing genome-editing toolbox [1]. Three
key features of this approach are that, first, the FEN-1
fusion can use DNA oligomers to target a specific locus;
second, targeting using this approach has a tendency to
create larger deletions on the order of several hundreds
to thousands of bases, and finally, the authors were able
to demonstrate that this approach works in zebrafish
embryos, showing that targeting is possible in an animal
model.
Structure-guided nuclease-mediated DNA editing uses
an engineered SGN comprising FEN-1, which recognizesa 3′ “flap” structure (consisting of a double-stranded
helix where one strand is shorter, creating a flap at the
end; Fig. 1), and the cleavage domain of the Fok1 endo-
nuclease. FEN-1 uses a guide DNA comprising a (mini-
mum) 20 base-pair (bp) complementary sequence to the
target site where the 3′ end has a single-base mismatch
creating an unpaired base, forming the “flap” structure.
Similar to ZFNs and TALENS, in the SGN strategy, the
two halves of the Fok1 endonuclease are brought
together by two adjacent targets on opposite strands, in
essence creating a 40-bp or longer target sequence
(Fig. 1).
Xu and colleagues tested different lengths of guide
DNA, ranging from 10–60 nucleotides. SGN failed to
cleave targets that were less than 20 nucleotides but
good cutting efficiency was achieved for 20–60 bp DNA
guides. Although the authors were able to demonstrate
convincingly that SGN cuts single-stranded target DNA
using guide DNAs of 20–60 nucleotides, no quantifica-
tion of cutting efficiencies was reported. Based on visual
inspection of the polyacrylamide gel electrophoresis
(PAGE) results, it is possible that the guide DNAs of
length 50 nucleotides were the most efficient size for
cutting, but additional experiments are needed to verify
this possibility and to evaluate the general efficacy of
SGNs in vivo. Given that a 3′ unpaired flap is essential
for FEN-1 to recognize the target, Xu and colleagues
tested all possible 3′ nucleotide mismatches (C-T, G-T,
T-T, C-A, G-A, A-A, C-C, A-C, T-C, A-G, T-G, G-G)
and were not able to detect any differences in their
DNA cutting efficiencies. More quantification data will
be helpful in determining the effect of unpaired bases on
the cutting efficiency.
SGNs cut the target sites 9–10 nucleotides away from
the 3′ end of the guide DNA. Xu et al. extended their
in vitro studies by testing the ability of SGNs to edit
genes in vivo by using zebrafish embryos. First, they
injected two guide DNAs targeting enhanced green
fluorescent protein (eGFP) with SGN mRNA into one-
cell-stage embryos. These injections generated mutations
in up to 25 % of the sequenced eGFP DNA. The authors
also tested the effect of distance between the two guides
on mutagenesis efficiencies. The guide DNA pairs
spaced by 0, 8, 18, 32, and 50 bp generated mutations
with 4, 0, 6.5, 18, and 25 % efficiencies, respectively. In
addition to eGFP, the authors targeted two zebrafish
genes—znf703 and cyp26b1—and were able to generate
genomic mutations with ~10 % efficiency. The muta-
genic efficiencies were low compared with those of
CRISPR-Cas9 but there are still significant opportunities
to optimize the efficacy of the approach.
For ZFNs, TALENs, and CRISPR/Cas9, one common
feature is that the insertions and deletions generated by
the double-stranded break are typically small, most
Fig. 1 Genome editing using a structure-guided endonuclease (SGN). SGN-mediated genome editing has two components: a SGN consisting of
the FEN-1 enzyme fused with the Fok1 endonuclease and two 20–60-nucleotide target sequences with single, 3′ unpaired bases (3′ Flap). The
two guides bind to the complementary sequences and the FEN-1 component of SGN recognizes the 3′ flap structure and guides the Fok1 dimer
into position to generate a double-stranded cut, which then repairs by non-homologous end joining after what appears to be an expansion of
the deleted region by a currently unknown mechanism
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nucleotides. The in vivo deletions identified using an
SGN approach were much larger, ranging from approxi-
mately 650 to 2600 bp. It is currently unknown why
these larger deletions are being generated but it poten-
tially has something to do with the normal functions of
FEN-1, which has been implicated in both DNA repair
and replication. The combination of Fok1 activity and
FEN-1 together might cause a “chain reaction” that cre-
ates deletions larger than those simple double-stranded
breaks generated by the other techniques. When target-
ing genes for inactivation, it is obviously advantageous
to be able to generate larger deletions to ensure that
gene function is truly disrupted. Occasionally false-
negatives can arise because a smaller, frame-shiftingmutation is masked biologically by compensation mecha-
nisms. A larger deletion can prevent these potential errors.
Concluding remarks
In the rapidly changing landscape of genome editing, the
SGN approach is an exciting new option. The flexibility
and simplicity of DNA-guided genome targeting is a
major strength, as is its potential for generating larger
deletions. Given the endogenous DNA repair functions
of FEN-1, it will be interesting to see in the future
whether there is a potential to stimulate specific changes
in sequence using repair templates. With validation from
other laboratories, the work of Xu and colleagues could
result in an important alternative to RNA-guided Cas9
for genome engineering.
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